| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 05/11/2005 | CN1615308A Prucalopride-N-oxide |
| 05/11/2005 | CN1615307A Process and intermediates for pyridazinone antidiabetic agents |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/11/2005 | CN1615300A Benzimidazole derivatives and their use as GNRH antagonists |
| 05/11/2005 | CN1200940C Triazole pyrimidine compounds |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200933C Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents |
| 05/10/2005 | US6890940 Immoglobulin E (IgE) antibody production inhibitor; treating allergic immune diseases such as asthma, dermatitis, inflammatory bowel disease and allergic opthalmopathy |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890935 Pharmaceutical compositions and methods for use |
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | US6890930 Quinazolinones |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890885 Herbicidal composition |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040345A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040156A1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 05/06/2005 | WO2005040155A1 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 05/06/2005 | WO2005040151A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| 05/06/2005 | WO2005040132A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | WO2005040131A1 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005039496A2 Inhibitors of cathepsin s |
| 05/06/2005 | WO2005028443A3 Protein tyrosine kinase enzyme inhibitors |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543644A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | CA2543079A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 05/06/2005 | CA2539726A1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096378 Fundic relaxation; dyspepsia, early satiety, bloating and anorexia; 1-[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl- )methyl]amino]-2-hydroxypropyl]-2,4-imidazolidinedione |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096359 melanocortin receptor agonist, antagonist; preventing or treating inflammatory diseases, AIDS, obesity, bulimia, anorexia or sexual dysfunction; N-(2-aminoethyl)-3'-[1-{N-(1-benzylpiperidin-4-yl)-N-(2-naphthylacetyl)aminoethyl][1,1'-biphenyl)-2-carboxamide dihydrochloride |
| 05/05/2005 | US20050096354 Process for the preparation of substituted aryl pyrazoles |
| 05/05/2005 | US20050096347 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 05/05/2005 | US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/05/2005 | US20050096278 Antibacterial agents |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527067A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 05/04/2005 | EP1527062A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 05/04/2005 | EP1527053A1 Process for preparing rizatriptan |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1159254B1 Oxyalkylene-substituted aminophenol intermediate |
| 05/04/2005 | EP1119567B1 Quinazoline derivatives |
| 05/04/2005 | EP0946537B1 Process for the stereoselective production of nitro-enamine compounds |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | EP0755923B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| 05/04/2005 | CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199963C Coumarin derivatives with COMT inhibiting activity |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199947C Process for production of pyridine derive |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887893 Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/03/2005 | US6887889 Aryl and biaryl piperdines with MCH modulatory activity |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887873 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887864 Anticancer agents, a benzoylamino-azepan-3-yl-isonicotinamide compounds |
| 05/03/2005 | US6887854 Absorption, fluorescence; using light for optical medical diagnosis |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 05/03/2005 | CA2149886C Process for preparing tetrazolyl-benzopyranones |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037825A2 Protein kinase inhibitors |
| 04/28/2005 | WO2005037824A2 Method for the production of amino crotonyl compounds |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037796A1 Compounds and methods for treating dyslipidemia |
| 04/28/2005 | WO2005037791A1 Compositions and methods for viral inhibition |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |